Publications & Presentations

Gerstman, B. Burt

Publications

  • Gerstman, B. B. (2023). There is no single gold standard study design (RCTs are not the gold standard). Expert Opinion on Drug Safey, 1-4. doi:10.1080/14740338.2023.2203488 
  • Gerstman, B.B. (2021). Proton pump inhibitors and chronic kidney disease: reevaluating the evidence from a randomized controlled trial. Pharmacoepidemioly and Drug Safety 2021; 30(1):4–8.
  • Gerstman, B.B.. "Basic Biostatistics. Second Edition" Jones & Bartlett. Book. Boston: Jones & Bartlett, (2014).
  • Gerstman, B.B.. "Epidemiology Kept Simple: An Introduction to Traditional and Modern Epidemiology. 3rd edition, " Wiley-Blackwell. Book. Oxford: Wiley-Blackwell, (2013).
  • Gerstman, B.B.. "Statistical issues in the interpretation of studies of lumbar intervertebral measurements. " Article. Vol. 36. Issue 19. (2011). pp.1616-8.
  • Woodfield, H. C., Gerstman, B. B., Olaisen, R. H., & Johnson, D. C. . "Inter-examiner reliability of supine leg checks for discriminating leg length inequality." Journal of Manipulative and Physiological Therapeutics.. Article. Vol. 34. Issue 4. Journal of Manipulative and Physiological Therapeutics., (2011). pp. 239-246.
  • Gerstman, B.B.. "Basic Biostatistics" Jones & Bartlett. Book. Boston: Jones & Bartlett, (May 2008).
  • B. Burt Gerstman. "William Farr's survival analyses" Birkhhuser Verlag. Article. Birkhhuser Verlag, (October 2004).
  • B. Burt Gerstman. "Comments regarding On Prognosis by William Farr (1838), with reconstruction of his longitudinal anal" Social and Preventive Medicine (Soz Praventivmed). Article. Vol. 48. Social and Preventive Medicine (Soz Praventivmed), (July 2003). pp.285-289.
  • B. Burt Gerstman. "Epidemiology kept simple: An introduction to traditional and modern epidemiology (2nd ed.)." Book. (January 2003).
  • B. Burt Gerstman. "Epidemiology Kept Simple: Introduction to Traditional and Modern Epidemiology (2nd edition)" John Wiley & Sons. Book. John Wiley & Sons, (December 2003).
  • B. Burt Gerstman. "StatPrimer" SJSU website. Book. SJSU website, (January 2003).
  • B. Burt Gerstman. "Cohort studies: history of the method" Article. Vol. 47. (January 2002). pp.90.
  • B. Burt Gerstman. "Health professionals do not understand mathematical models (letter)" Article. (July 2002).
  • B. Burt Gerstman. "Epidemiology Kept Simple: An Introduction to Classic and Modern Epidemiology" John Wiley. Book. John Wiley, (December 1998).
  • B. Burt Gerstman. "The reliability of muscle function analysis using different methods of stimulation." Article. (January 1998).
  • B. Burt Gerstman. "Decreasing the number of recheck appointments for an urgent care clinic by using telephoned follow-u" Article. (January 1996).
  • B. Burt Gerstman. "Depression in new users of beta-blockers and selected anti-hypertensives" Article. (December 1996).
  • B. Burt Gerstman. "Steroidal contraceptive use update, United States, 1989-1994." Article. (January 1996).
  • B. Burt Gerstman. "Baldness and coronary heart disease rates in men from the Framingham study" Article. Vol. 142. Issue 8. (October 1995). pp.829-833.
  • B. Burt Gerstman. "Student evaluations of teaching effectiveness: The interpretation of observational data and the pri" Article. (January 1995).
  • B. Burt Gerstman. "Variations in the use of medication for the treatment of childhood asthma in the Michigan medicaid" Article. (January 1993).
  • B. Burt Gerstman. "Intestinal necrosis associated with postoperative orally administered sodium polystyrene sulfonate i" Article. (January 1992).
  • Gerstman BB, Kirkman R, Platt R. Intestinal necrosis following the use of post-operative orally administered sodium polystyrene sulfonate in sorbitol. American Journal of Kidney Diseases 1992; 20:159-161.
  • Gerstman BB. Epidemiologic critique of the Japanese Committee on the Safety of Contrast Media's report on adverse reactions to ionic and nonionic media. Radiology 1991; 178:787-790.
  • Gerstman BB, Lundin FE, Stadel BV, Faich GA. A method of pharmacoepidemiologic analysis that uses computerized Medicaid data. Journal of Clinical Epidemiology 1990;43:1387-1393.
  • Gerstman BB, Piper JM, Tomita DK, Ferguson WJ, Stadel BV, Lundin FE. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. American Journal of Epidemiology 1991; 133:32-37.
  • Gerstman BB, Gross TP, Kennedy DL, Tomita DK, Bennett RC. Trends in the content and use of oral contraceptives in the United States, 1964-1988. American Journal of Public Health 1991; 81:90-98.
  • Gerstman BB, Lundin FE. Pharmacoepidemiologic follow-up using computerized linked data. 1990 Proceedings of the Biopharmaceutical Section of the American Statistical Association. Alexandria, VA: American Statistical Association. April 1991.
  • Gerstman BB, Piper JM, Freiman JP, et al. Oral contraceptive estrogen and progestin potencies and the incidence of deep venous thromboembolism. International Journal of Epidemiology 1990; 19:931-936.
  • Gerstman BB, Freiman JP, Hine LK. Use of subsequent anticoagulants to increase the predictive value of Medicaid deep venous thromboembolism diagnoses. Epidemiology 1990; 1:122-7.
  • Gerstman, BB. Episheets(software). Described In EpiSource: A Guide to Resources in Epidemiology, Roswell, GA, 1991, p. 1007.
  • Gerstman BB. Re: use of the term pharmacoepidemiology. American Journal of Epidemiology 1990; 131:1101 (letter).
  • Gerstman BB, et al. Exploration of drug-associated risk using health care coverage data bases. Proceedings of the 5th International Conference on Pharmacoepidemiology. Detroit, MI: Lewis Publishers. (Abstract: J Clin Research Drug Dev 1989;3:210.)
  • Gerstman BB, Bosco LA, Tomita DK. Prevalence and outpatient treatment of asthma in the Michigan Medicaid patient population younger than 45, 1980-1986. Journal of Allergy and Clinical Immunology 1989; 83:1032-9.
  • Gerstman BB, Lundin FE. Discussion of longitudinal follow-up in claims-based pharmacoepidemiologic databases. Proceedings of the 5th International Conference on Pharmacoepidemiology. Detroit, MI: Lewis Publishers.
  • Gerstman BB. EpiSheet: Microcomputer Spreadsheet Templates for Epidemiologic Analysis. Roswell, GA. Distributed by the Epidemiology Monitor. Described in the Epidemiology Monitor, Roswell, GA. First listed in a 1987 Epidemiology Monitor followed by a listing in 1988(5);5.
  • Gerstman BB. Consideration of feline leukemia virus vaccine interventions using a modified Reed-Frost epidemiologic model. Am J Epidemiol 1988; 128:939-40 (abstract).
  • Gerstman BB. Epidemiologic calculations, graphs, and "what-if" analysis on a microcomputer spreadsheet. Am J Epidemiol 1987; 126:778 (abstract).
    Gerstman BB. On transferring data from different sources. The Epidemiology Monitor 1987; 8(3):2-4.
  • Gerstman BB. Epidemiologic studies of potassium chloride formulation and the risk of upper gastrointestinal bleeding. Post-Marketing Surveillance News Quarterly 1987;(July-September):5.
  • Gerstman BB. Pet ownership and well-being. Compendium of Continuing Education for Practicing Veterinarians 1987; 9:131-138.
  • Gerstman BB, Cappucci DT. Evaluating the reliability of diagnostic test results. J Am Vet Med Assoc 1986; 188:248-251.
  • Gerstman BB. Similarities between clinical diagnosis and biomedical research (letter). J Am Vet Med Assoc 1986;189:20-21.
  • Gerstman BB. Why views on animals are so diverse. San Jose Mercury News. January 6, 1985, pp C1 and C5.
  • Gerstman BB. Sources of nosocomial infections in immunocompromised patients (letter). Calif Vet 4:27,1983.
  • Gerstman BB. The epizootiology of feline leukemia virus and its associated diseases. Compendium of Continuing Education for Practicing Veterinarians 1985; 7:767-776.
  • Brooks SD, Gerstman BB, Sucher KP, Kearns PJ. The reliability of muscle function analysis using different methods of stimulation. Journal of Parenteral and Enteral Nutrition 1998; 22:331-334.
  • Bedeian K, Hively JM, Gerstman BB, Dhanoa D. Decreasing the number of recheck appointments for an urgent care clinic by using telephoned follow-up care by nurses. HMO Practice 1996; 10:44-45.
  • Herrera C, D'Agostino R, Gerstman B, Bosco L, Belanger A, Kannel W. Baldness and coronary heart disease in Framingham men. American Journal of Epidemiology 1995; 142:828-33.
  • Bosco LA, Gerstman BB, Tomita DK. Variations in the use of medication for the treatment of childhood asthma in the Michigan Medicaid population, 1980-1986. Chest 1993; 104:1727-33.
  • Jolson HM, Bosco L, Bufton MG, Gerstman BB, Rinsler SS, Williams E, et. al. Cerebellar toxicity associated with high dose cytarabine therapy. Journal of the National Cancer Institute 1992;84:500-505.
  • Arrowsmith JA, Gerstman BB, Fleischer DE, Benjamin SB. Results from the American Society of Gastroenterology / U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointestinal Endoscopy; 1991:27:421-427.
  • Hine LK, Gerstman BB, Wise RW, Tsong Y. Fatal blood dyscrasias in the U.S., 1984. American Journal of Medicine 1990; 88:151-3.
  • Bosco LA, Knapp DE, Gerstman BB. Anti-asthma drug use in the United States, 1973-1985. Journal of Allergy and Clinical Immunology 1987; 3:398-402.
    Division of Epidemiology and Surveillance. Deaths associated with thiamine-deficient parenteral nutrition. MMWR 1989; 38:3:43.
  • Wise RP, Tsong Y, Gerstman BB, et al. Surveillance of drug related-mortality, U.S., 1984-1986. Proceedings of the 5th International Conference on Pharmacoepidemiology. Detroit, MI: Lewis Publishers. (Abstract: J Clin Research Drug Dev 1989;3:229.)
  • Wise RW, Tsong Y, Gerstman BB. Drug-related mortality in the United States, 1984. Proceedings of the 4th International Conference on Pharmacoepidemiology. Detroit, MI: Lewis Publishers. (Abstract: J Clin Research Drug Dev 1988;2:181-2.)
  • Tomita DK, Gerstman BB, Lundin FE. Description of the Michigan Medicaid population and use of this information in pharmaco-epidemiologic studies. Proceedings of the 4th International Conference on Pharmacoepidemiology. Detroit, MI: Lewis Publishers. (Abstract: J Clin Research Drug Dev 1988;2:195-6.)
    Presentations and other relevant experience available upon request.